EPISODE · Jul 31, 2025 · 31 MIN
Pharmacy’s Never Ending Story: PBM Reform Act and Medicare Drug Pricing Changes with Doug Hoey, NCPA
from The Bottom Line Pharmacy Podcast: Sykes & Company, P.A. · host Sykes & Company, P.A.
Send us Fan MailSchedule an Rx AssessmentSubscribe to Master The MarginH.R. 4317, PBM transparency and Medicare drug pricing...The legislative landscape is shifting fast, and if pharmacy owners want a sustainable future, advocacy can’t be optional.So where do things stand and what’s next?In this episode of The Bottom Line Pharmacy Podcast, Scotty Sykes, CPA, CFP®, and Bonnie Bond, CPA, sit down with B. Douglas Hoey, CEO of the NCPA, to discuss:- What the PBM Reform Act means for pharmacy reimbursement- How Medicare drug pricing changes will impact your margins- Why advocacy doesn’t stop after a legislative winAnd more!More About Our Guest:Douglas Hoey is the Chief Executive Officer of the National Community Pharmacists Association. NCPA represents the owners of nearly 20,000 pharmacy small businesses who’s pharmacists provide prescription dispensing services and help fill primary care gaps. The majority of these pharmacies are located in areas the CDC ranks as “high” or “very high” on the Socially Vulnerable Index. Consumers consistently rank community pharmacies as the top-rated pharmacies in the country. Hoey is a licensed pharmacist in Oklahoma, Virginia, and Texas and practiced in community pharmacies including his family’s pharmacy before coming to NCPA. He is widely quoted by media as an industry expert on community pharmacy payment and practice issues. Hoey also developed and taught pharmacology courses at George Washington and Marymount universities. He is President of the World Pharmacy Council, co-Chairman of the Board of Directors for Surescripts, Chairman of the NCPA Innovation Center, and co-Chairman of the CPESN-USA Board. His pharmacy degree is from the University of Oklahoma and his MBA is from the Oklahoma City University. Learn more about Doug and the NCPA:Doug Hoey LinkedInNCPA FacebookNCPA InstagramNCPA LinkedInNCPA YouTubeNCPA Twitter (X)NCPA WebsiteStay connected with us:FacebookTwitterLinkedInScotty Sykes – CPA, CFP LinkedInScotty Sykes – CPA, CFP TwitterMore Resources on these Topics:Podcast – The One Big, Beautiful BillPodcast - Momentum on the Hill: Protecting Independent Pharmacies Through AdvocacyPodcast - The Trusted Pharmacist: Advocacy and Building a Resilient Pharmacy
Embed this episode
What this episode covers
Send us Fan Mail Schedule an Rx Assessment Subscribe to Master The Margin H.R. 4317, PBM transparency and Medicare drug pricing...The legislative landscape is shifting fast, and if pharmacy owners want a sustainable future, advocacy can’t be optional. So where do things stand and what’s next? In this episode of The Bottom Line Pharmacy Podcast, Scotty Sykes, CPA, CFP®, and Bonnie Bond, CPA, sit down with B. Douglas Hoey, CEO of the NCPA, to discuss: - What the PBM Reform Act means for pha...
NOW PLAYING
Pharmacy’s Never Ending Story: PBM Reform Act and Medicare Drug Pricing Changes with Doug Hoey, NCPA
No transcript for this episode yet
Similar Episodes
No similar episodes found.
Similar Podcasts
No similar podcasts found.